A relevant in vitro human model for the study of Zika virus antibody-dependent enhancement

J Gen Virol. 2017 Jul;98(7):1702-1712. doi: 10.1099/jgv.0.000833. Epub 2017 Jul 8.

Abstract

Zika virus (ZIKV) is a mosquito-borne flavivirus that has recently been responsible for a serious outbreak of disease in South and Central America. Infection with ZIKV has been associated with severe neurological symptoms and the development of microcephaly in unborn fetuses. Many of the regions involved in the current outbreak are known to be endemic for another flavivirus, dengue virus (DENV), which indicates that a large percentage of the population may have pre-existing DENV immunity. Thus, it is vital to investigate what impact pre-existing DENV immunity has on ZIKV infection. Here, we use primary human myeloid cells as a model for ZIKV enhancement in the presence of DENV antibodies. We show that sera containing DENV antibodies from individuals living in a DENV-endemic area are able to enhance ZIKV infection in a human macrophage-derived cell line and primary human macrophages. We also demonstrate altered pro-inflammatory cytokine production in macrophages with enhanced ZIKV infection. Our study indicates an important role for pre-existing DENV immunity on ZIKV infection in primary human immune cells and establishes a relevant in vitro model to study ZIKV antibody-dependent enhancement.

MeSH terms

  • Adult
  • Antibodies, Viral / immunology*
  • Antibody-Dependent Enhancement / immunology*
  • Cell Line, Tumor
  • Child
  • Child, Preschool
  • Cross Reactions / immunology
  • Cytokines / biosynthesis
  • Dengue / immunology
  • Dengue / virology
  • Dengue Virus / immunology*
  • Disease Outbreaks
  • Female
  • Humans
  • Infant
  • Macrophages / immunology*
  • Male
  • U937 Cells
  • Zika Virus / immunology*
  • Zika Virus Infection / immunology
  • Zika Virus Infection / pathology*
  • Zika Virus Infection / virology

Substances

  • Antibodies, Viral
  • Cytokines